Adriamycin-associated cardiomyopathy: where are we now? updates in pathophysiology, dose recommendations, prognosis, and outcomes
Sign Up to like & getrecommendations! Published in 2019 at "Current Opinion in Cardiology"
DOI: 10.1097/hco.0000000000000617
Abstract: Purpose of review Advances in cancer treatments have resulted in significant improvements in survival. Anthracycline chemotherapeutics play a major role in the treatment of hematologic malignancies and solid tumors; however, there is a risk of… read more here.
Keywords: prognosis outcomes; anthracycline; recommendations prognosis; anthracycline cardiomyopathy ... See more keywords